On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...
A new drug has been approved ... new class of medications for the brain disorder in several decades, according to a press release. "Today’s landmark approval of our first-in-class treatment ...
A unique peek inside the human brain may help explain how it clears away waste like the kind that can build up and lead to ...
Scientists have uncovered a mechanism in the brain that explains how drugs like methamphetamine and PCP impair cognitive ...
The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom ...
In a breakthrough for people with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication, which will be marketed under the name ...
PTC Therapeutics (PTCT) annoucned that the FDA accepted its marketing application for experimental brain diroser therapy ...
The U.S. Food and Drug Administration has approved a new drug for adults with ... treat the disease that targets what are known as the brain's cholinergic receptors instead of dopamine receptors ...
No new treatments for schizophrenia have been approved ... brain while tamping it down elsewhere in the body. He and his team tested 7,000 compounds and eventually combined xanomeline with a drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback